BLT 0.00% 2.6¢ benitec biopharma limited

New interview, page-36

  1. 1,775 Posts.
    lightbulb Created with Sketch. 169
    J8 - Why do you say cohort 4 can't start "in a few weeks". Under cohort 3, patients 7 and 8 are in parallel, and info to date suggests that they are on schedule. Here's my take on the schedule, as posted 25/6/15. Note that in each cohort part 1 is 1 patient, part 2 is 2 patients:

    Revised timetable
    http://hotcopper.com.au/threads/revised-timetable.2541252/#post-15527282

    First patient in cohort 3 has been dosed as at 25/6, so we're ahead of schedule (that is, ahead of the schedule I drafted). Leaving the inter-cohort delays the same as before - allowing 3 weeks per review and an extra 2 weeks between cohorts -

    - the timetable looks something like :
    Cohort 2 part 2 (4th&5th patient) ended 25 Jun (was expected 11 Jul).
    Cohort 3 part 1 ends [+ 6wks + 3 wks] 26 Aug (was 12 Sep).
    Cohort 3 part 2 ends [+ 6wks + 3wks + 2wks] 11 Nov (was 28 Nov).
    Cohort 4 part 1 ends [+ 10wks + 3wks ] 10 Feb 2016 (was 27 Feb 2016).
    Cohort 4 part 2 ends [+ 10wks + 3wks + 2wks] 25 May 2016 (was 11 Jun 2016).
    Cohort 5 part 1 ends [+ 10wks + 3wks ] 24 Aug 2016 (was 10 Sep 2016).
    Cohort 5 part 2 ends [+ 10wks + 3wks + 2wks] 7 Dec 2016 (was 24 Dec 2016).

    Not much change yet (17 days), but if they shorten the delay between cohorts again I'll start shortening them in the timetable. Saving 2 weeks every time would save 12 weeks overall.

    Nice to be ahead of schedule for once, instead of endless delays.

    Original timetable : http://hotcopper.com.au/threads/timetable.2513738/#.VYtH30a2Gc4
 
watchlist Created with Sketch. Add BLT (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.